Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
To Pay for Weight Loss Drugs, Some Take Second Jobs, Ring Up Credit-Card Debts
Some people are paying more than $10,000 a year for Ozempic and Mounjaro. Source link
Employers Cut Off Access to Weight-Loss Drugs for Workers
Costs are mounting for popular drugs such as Wegovy, a cousin of Ozempic, and healthcare plans are restricting coverage to save money. Source link
U.K. Reviews Safety of Ozempic, Other Weight-Loss Drugs
Drug regulators said they have received several reports of suspected suicidal and self-injurious behavior in patients taking the drugs. Source link
Drugs Like Ozempic Created a Gold Rush. These Drugmakers Want In.
Companies developing weight-loss drugs have raised or made deals valued at more than $1.4 billion since about a year ago. Source link
Strong U.S. demand eases pressure on Novo to show weight-loss drug’s health benefits By Reuters
© Reuters. FILE PHOTO: A selection of injector pens for the Wegovy weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S.,
Sex, Drugs and Spreadsheets: Dr. Glazer Treats Wall Street's Addiction Surge
Demand has exploded for Dr. Glazer’s practice, which treats traders, fund managers and bankers who battle mental-health problems. Source link
Obesity Drugs Won't Starve These Other Potential Blockbusters
Stocks of developers of fatty liver disease treatments had been on a tear until results from Eli Lilly’s medication were published last week. Source link
Biotech firms target weight-loss drugs without Wegovy’s side-effects By Reuters
© Reuters. FILE PHOTO: A selection of injector pens for the Wegovy weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S.,
Demand for Obesity Drugs Has Insurers Paying Close Attention
Markets Heard on the Street Strong sales of obesity-diabetes drugs known as GLP-1s could affect insurance companies’ financial results Source link
Hype Around Weight-Loss Drugs Shows No Signs of Abating. Neither Do the Ads.
Ads for the likes of Ozempic and Wegovy are spreading through social media feeds, subway stations and TV. Source link